Switch theme
Sign up to access all valuation multiples
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
2008
46
LTM Revenue $3.4M
Last FY EBITDA -$9.8M
$20.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Evaxion has a last 12-month revenue (LTM) of $3.4M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Evaxion achieved revenue of $3.3M and an EBITDA of -$9.8M.
Evaxion expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Evaxion valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.4M | XXX | $3.3M | XXX | XXX | XXX |
| Gross Profit | $3.4M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$9.8M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -293% | XXX | XXX | XXX |
| EBIT | -$14.9M | XXX | -$14.7M | XXX | XXX | XXX |
| EBIT Margin | -436% | XXX | -441% | XXX | XXX | XXX |
| Net Profit | -$11.9M | XXX | -$10.6M | XXX | XXX | XXX |
| Net Margin | -350% | XXX | -316% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $3.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Evaxion's stock price is $2.
Evaxion has current market cap of $15.5M, and EV of $20.6M.
See Evaxion trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $20.6M | $15.5M | XXX | XXX | XXX | XXX | $-0.72 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Evaxion has market cap of $15.5M and EV of $20.6M.
Evaxion's trades at 6.2x EV/Revenue multiple, and -2.1x EV/EBITDA.
Equity research analysts estimate Evaxion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Evaxion has a P/E ratio of -1.3x.
See valuation multiples for Evaxion and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $15.5M | XXX | $15.5M | XXX | XXX | XXX |
| EV (current) | $20.6M | XXX | $20.6M | XXX | XXX | XXX |
| EV/Revenue | 6.0x | XXX | 6.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -2.1x | XXX | XXX | XXX |
| EV/EBIT | -1.4x | XXX | -1.4x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.3x | XXX | -1.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -1.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEvaxion's last 12 month revenue growth is 14%
Evaxion's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Evaxion's rule of 40 is -29305% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Evaxion's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Evaxion and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -293% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -29305% | XXX | -278% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 313% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 541% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Evaxion acquired XXX companies to date.
Last acquisition by Evaxion was XXXXXXXX, XXXXX XXXXX XXXXXX . Evaxion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Evaxion founded? | Evaxion was founded in 2008. |
| Where is Evaxion headquartered? | Evaxion is headquartered in United States of America. |
| How many employees does Evaxion have? | As of today, Evaxion has 46 employees. |
| Who is the CEO of Evaxion? | Evaxion's CEO is Mr. Christian Kanstrup. |
| Is Evaxion publicy listed? | Yes, Evaxion is a public company listed on NAS. |
| What is the stock symbol of Evaxion? | Evaxion trades under EVAX ticker. |
| When did Evaxion go public? | Evaxion went public in 2021. |
| Who are competitors of Evaxion? | Similar companies to Evaxion include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Evaxion? | Evaxion's current market cap is $15.5M |
| What is the current revenue of Evaxion? | Evaxion's last 12 months revenue is $3.4M. |
| What is the current revenue growth of Evaxion? | Evaxion revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Evaxion? | Current revenue multiple of Evaxion is 6.0x. |
| Is Evaxion profitable? | Yes, Evaxion is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
